Table 8.
Disease outcomes
Proportion of patients (%) | Molnupiravir (%) | Best supportive care (%) |
---|---|---|
Total alive, acute phase | 99.88 | 98.71 |
Total dead, acute phase | 0.12 | 1.29 |
Proportion hospitalized | 6.38 | 9.20 |
Proportions in those who were alive at the end of the acute phase, by highest level of care | ||
Outpatient | 93.62 | 90.80 |
General ward | 4.84 | 6.32 |
Intensive care unit | 0.87 | 1.15 |
Mechanical ventilation | 0.55 | 0.43 |
Proportions in those who died at the end of the acute phase, by highest level of care | ||
General ward | 0.02 | 0.14 |
Intensive care unit | 0.04 | 0.43 |
Mechanical ventilation | 0.06 | 0.72 |
Proportion readmitted | 1.20 | 1.47 |
Proportions of those who survived the acute phase and experienced long-term sequelae, by highest level of care | ||
Outpatient | 41.12 | 39.88 |
General ward | 3.71 | 4.84 |
Intensive care unit | 0.85 | 1.12 |
Mechanical ventilation | 0.52 | 0.41 |